eBook: Increase Time to Market with Precision Dispensing Technology
Discover how to make safe, productive, efficient bioprocessing a reality by exploring the benefits of precision dispensing technology.
Process Development
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News | Process Development
Capricor, Lonza Enter CAP-1002 Development Agreement
Lonza will perform process development activities for late-clinical and commercial-scale GMP manufacturing of CAP-1002.Contract Pharma Staff 01.12.21
-
Breaking News | Industry News | Process Development
Sartorius to Acquire Novasep's Chromatography Biz
Novasep's division expects to generate sales of approximately €37 million in 2020 with double-digit profit margins.Contract Pharma Staff 01.06.21
-
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News | Process Development | Scale-up/Technology Transfer
CHA Biotech Launches Global CDMO Biz
Matica Biotechnology to construct GMP facility for viral vector production in Texas.Contract Pharma Staff 12.16.20
-
Clinical Trials | Fill/Finish | Formulation Development | Lyophilization | Process Development | Vials
Emergent BioSolutions
Emergent BioSolutions provides contract manufacturing services for bulk drug substances and sterile injectable drug products.Syed T. Husain, SVP & Head of CDMO Business Unit 12.01.20
-
Capsules | Formulation Development | Methods Development | Process Development | Validation
-
Chemistry | Drug Development | Formulation Development | Process Development
-
Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Process Development | Process Validation
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.10.22.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development
Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals
Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.Contract Pharma Staff 09.30.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Process Development
Samsung Biologics Inks Service Pact with Panolos Bioscience
Will provide cell line development, process development, and clinical material manufacturing for PB101, an Fc-fusion protein to treat solid tumors.Contract Pharma Staff 09.17.20
-
APIs | Breaking News | Chemistry | Collaborations & Alliances | Industry News | Process Development
Faes Farma Chooses Syrris Asia to Develop Continuous Flow Processes
Acquired a Syrris Asia system in early 2018 with the aim of developing a new synthetic pathway for an existing API.Contract Pharma Staff 09.08.20
-
Breaking News | Process Development | Promotions & Moves
Romanco Appoints Joint Managing Director of Romanco Innojet
Michael Van den Bossche brings two decades of experience.Contract Pharma Staff 08.04.20
-
Bioanalytical Services | Breaking News | Industry News | Process Development
Lonza Expands Particle Engineering Services
Expands jet milling and spray dry processing for development at U.S. and European sites and enhances specialized processing capabilities.Contract Pharma Staff 07.01.20
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Drug Development | Process Development
Arranta Bio Expands Microbiome Capacity at CoE
Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.Contract Pharma Staff 05.28.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Drug Development | Process Development
Samsung Biologics, PharmAbcine Enter Antibody Pact
To develop and manufacture PMC-402, a next-gen therapeutic antibody candidate to treat oncology and neovascular disordersContract Pharma Staff 04.06.20
-
Bio News | Breaking News | cGMP Manufacture | Process Development
Immunogenesis, ProBioGen Enter Large-Scale Mfg. Pact
To provide cell line development, process development and GMP manufacture of Immunogenesis’ lead immuno-oncology candidate03.25.20
-
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News | Process Development
Indapta, Lonza Form Immuno-oncology Partnership
Lonza to provide process development, clinical manufacturing and regulatory support for IND filing.01.13.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
Alcami to Expand Charleston Ops
$17 million investment will add 6,000 sq.-ft., substantially augmenting capacity for sterile drug product development and manufacturing12.19.19
-
APIs | Process Development | Validation
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Process Development
